Acute Lymphoblastic Leukemia Recurrent
5 clinical trials · Condition
◉ Watch Acute Lymphoblastic Leukemia Recurrent
| Record | Firm | Date |
|---|---|---|
| CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL (NCT04049383) | Medical College of Wisconsin | 2020-10-16 |
| Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia (NCT03957915) | Institut Paoli-Calmettes | 2020-05-29 |
| MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM) (NCT03853616) | Miltenyi Biomedicine GmbH | 2018-11-26 |
| International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia (NCT03705507) | University of Birmingham | 2018-05-18 |
Track Acute Lymphoblastic Leukemia Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.